Who
Robert Ticktin
General Counsel & COO
Company insider
Files Form 4 as: General Counsel & COO, PMV Pharmaceuticals; General Counsel, EPIRUS Biopharmaceuticals.
In numbers
- Trades disclosed
- 14
- Buys
- 1
- Sells
- 1
- Bought
- $11K
- Sold
- $25K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 16 Jul 2014
- Last trade
- 5 Mar 2026
- Last filed
- 9 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Mar 2026filed 9 Mar 2026 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —319,270 at $0.00 | filing |
| 5 Mar 2026filed 9 Mar 2026 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —319,270 at $0.00 | filing |
| 1 Jul 2025filed 3 Jul 2025 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $25K23,151 at $1.06 | filing |
| 27 May 2016filed 31 May 2016 | EPIRUS Biopharmaceuticalsoption or derivative | SEC FORM 4 Code A | —230,000 at $0.00 | filing |
| 27 Feb 2016filed 1 Mar 2016 | EPIRUS Biopharmaceuticals | SEC FORM 4 Code M | —949 | filing |
| 27 Feb 2016filed 1 Mar 2016 | EPIRUS Biopharmaceuticals | SEC FORM 4 Code M | —2,134 | filing |
| 27 Feb 2016filed 1 Mar 2016 | EPIRUS Biopharmaceuticalsoption or derivative | SEC FORM 4 Code M | —949 at $0.00 | filing |
| 27 Feb 2016filed 1 Mar 2016 | EPIRUS Biopharmaceuticalsoption or derivative | SEC FORM 4 Code M | —2,134 at $0.00 | filing |
| 21 Dec 2015filed 22 Dec 2015 | EPIRUS Biopharmaceuticals | SEC FORM 4 Bought | $11K3,000 at $3.72 | filing |
| 2 Nov 2015filed 3 Nov 2015 | EPIRUS Biopharmaceuticalsoption or derivative | SEC FORM 4 Code A | —39,474 at $0.00 | filing |
| 27 Feb 2015filed 2 Mar 2015 | EPIRUS Biopharmaceuticalsoption or derivative | SEC FORM 4 Code A | —65,006 at $0.00 | filing |
| 27 Feb 2015filed 2 Mar 2015 | EPIRUS Biopharmaceuticalsoption or derivative | SEC FORM 4 Code A | —949 at $0.00 | filing |
| 27 Feb 2015filed 2 Mar 2015 | EPIRUS Biopharmaceuticalsoption or derivative | SEC FORM 4 Code A | —8,534 at $0.00 | filing |
| 16 Jul 2014filed 17 Jul 2014 | EPIRUS Biopharmaceuticalsoption or derivative | SEC FORM 4 Code A | —99,442 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.